ColdPlay2: Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium
Study Details
Study Description
Brief Summary
Assess Cryoablation (CryoBalloon Ablation cryotherapy) for treatment of Dysplastic Barrett's Esophagus, Esophageal Squamous Dysplasia and early Esophageal Cancer. The cryoablation treatment will be offered as an alternative to standard ablation therapies such as Radiofrequency Ablation, Argon Plasma Coagulation and carbon dioxide Cryotherapy).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Cryoablation (cryotherapy) is an established type of mucosal ablation for treatment of various conditions in the GI tract, including Barrett's esophagus and esophageal cancer. The purpose of this study is to assess the safety, feasibility and performance of cryoablation system (the C2 Focal Cryoablation Device in patients with BE and esophageal squamous dysplasia who need ablation therapy for clinical standard care. The new cryoablation treatment will be offered as an alternative to standard ablation therapies already in place (radiofrequency ablation, carbon dioxide cryotherapy).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: CryoBalloon ablation Patients having ablation of dysplastic tissue in esophagus. |
Device: CryoBalloon
Esophageal tissue ablation with focal freezing using nitrous oxide via a single use balloon catheter
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Histological evaluation of treatment zone(s) for dysplasia [60 months]
evaluate histopathology of esophageal tissue for Barrett's dysplasia after cryoablation
- Number of patients with treatment-related adverse events (pain and dysphagia) [60 months]
evaluate by patient questionnaire for change from baseline in pain on the 11 point scale (0-10) from baseline to post treatment and incidence of dysphagia (using a standardized dysphagia scoring system 0-4) collected over treatment period.
Secondary Outcome Measures
- Histological evaluation of treatment zone for intestinal metaplasia (BE patients) [60 months]
evaluate histopathology of esophageal tissue for Barrett's esophagus (intestinal metaplasia) after cryoablation
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients recommended for ablation of either Barrett's esophagus with dysplasia or esophageal squamous dysplasia, scheduled for upper endoscopy.
Exclusion Criteria:
-
Patient unable to undergo endoscopy,
-
Patients with visible esophageal mass.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Johns Hopkins Hospital | Baltimore | Maryland | United States | 21287 |
Sponsors and Collaborators
- Johns Hopkins University
- Pentax Medical
Investigators
- Principal Investigator: Marcia Canto, MD, MPH, Johns Hopkins University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NA_00075654